| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.83 | 0.005 | 0.832 | Analgesic | 0.296 0.145 CID_23192118 0.832 0.005 CID_9929090 | CID_9929090 | |
| 0.821 | 0.002 | 0.821 | Substance P antagonist | 0.054 0.014 CID_23192118 0.794 0.002 CID_9929090 | ||
| 0.656 | 0.002 | 0.656 | Neurokinin 1 antagonist | 0.619 0.002 CID_9929090 | ||
| 0.652 | 0.003 | 0.652 | Neurokinin antagonist | 0.615 0.003 CID_9929090 | ||
| 0.479 | 0.017 | 0.479 | Potassium channel (Voltage-sensitive) blocker | 0.41 0.025 CID_23192118 0.371 0.032 CID_9929090 | ||
| 0.421 | 0.025 | 0.421 | HERG channel blocker | 0.374 0.032 CID_23192118 0.329 0.042 CID_9929090 | ||
| 0.474 | 0.099 | 0.554 | Antiinflammatory | 0.554 0.067 CID_9929090 | CID_9929090 | |
| 0.388 | 0.024 | 0.388 | Potassium channel blocker | 0.282 0.053 CID_23192118 0.285 0.052 CID_9929090 | ||
| 0.316 | 0.03 | 0.39 | Ca(v)3.3 blocker | 0.39 0.005 CID_23192118 0.268 0.075 CID_9929090 | CID_23192118 | |
| 0.324 | 0.045 | 0.359 | Antiamyloidogenic | 0.275 0.061 CID_23192118 0.359 0.037 CID_9929090 | CID_9929090 | |
| 0.345 | 0.084 | 0.347 | Toll-Like receptor 7 agonist | 0.347 0.084 CID_9929090 | CID_9929090 | |
| 0.273 | 0.018 | 0.273 | Nav1.2 sodium channel blocker | 0.201 0.034 CID_23192118 0.232 0.025 CID_9929090 | ||
| 0.336 | 0.09 | 0.336 | Toll-Like receptor agonist | 0.336 0.089 CID_9929090 | ||
| 0.228 | 0.013 | 0.346 | Nav1.6 sodium channel blocker | 0.346 0.005 CID_23192118 0.193 0.022 CID_9929090 | CID_23192118 | |
| 0.228 | 0.024 | 0.282 | Sodium channel blocker | 0.282 0.013 CID_23192118 0.13 0.074 CID_9929090 | CID_23192118 | |
| 0.233 | 0.033 | 0.233 | Cholinergic | 0.2 0.047 CID_9929090 | ||
| 0.197 | 0.005 | 0.266 | Glutamate (mGluR7) agonist | 0.266 0.003 CID_23192118 0.138 0.017 CID_9929090 | CID_23192118 | |
| 0.213 | 0.025 | 0.253 | Sodium channel (voltage-gated) blocker | 0.253 0.014 CID_23192118 0.126 0.078 CID_9929090 | CID_23192118 | |
| 0.168 | 0.005 | 0.168 | Glycine transporter inhibitor | 0.049 0.032 CID_23192118 0.104 0.011 CID_9929090 | ||
| 0.187 | 0.036 | 0.187 | Calcium channel blocker | 0.112 0.097 CID_23192118 0.123 0.084 CID_9929090 | ||
| 0.161 | 0.012 | 0.347 | Nav1.8 sodium channel blocker | 0.347 0.004 CID_23192118 0.124 0.019 CID_9929090 | CID_23192118 | |
| 0.187 | 0.05 | 0.187 | MAP kinase kinase 5 inhibitor | 0.178 0.066 CID_9929090 | ||
| 0.248 | 0.114 | 0.248 | Caspase 3 stimulant | 0.228 0.133 CID_23192118 0.245 0.116 CID_9929090 | ||
| 0.157 | 0.03 | 0.157 | Calcium channel (voltage-sensitive) blocker | 0.095 0.092 CID_23192118 0.116 0.062 CID_9929090 | ||
| 0.133 | 0.02 | 0.291 | NMDA 2 receptor antagonist | 0.14 0.019 CID_23192118 0.291 0.005 CID_9929090 | CID_9929090 | |
| 0.134 | 0.026 | 0.148 | Alpha 2a adrenoreceptor antagonist | 0.148 0.023 CID_23192118 0.077 0.05 CID_9929090 | CID_23192118 | |
| 0.121 | 0.036 | 0.121 | Alpha 2 adrenoreceptor antagonist | 0.108 0.043 CID_23192118 | ||
| 0.094 | 0.013 | 0.125 | MAP kinase 7 inhibitor | 0.125 0.004 CID_23192118 0.086 0.027 CID_9929090 | CID_23192118 | |
| 0.172 | 0.094 | 0.284 | Amyloid beta aggregation inhibitor | 0.284 0.048 CID_23192118 0.237 0.062 CID_9929090 | CID_23192118 | |
| 0.135 | 0.059 | 0.181 | Nav1.3 sodium channel blocker | 0.181 0.032 CID_23192118 0.105 0.092 CID_9929090 | CID_23192118 | |
| 0.15 | 0.076 | 0.235 | CF transmembrane conductance regulator agonist | 0.235 0.009 CID_23192118 0.171 0.045 CID_9929090 | CID_23192118 | |
| 0.116 | 0.043 | 0.116 | Hedgehog signaling inhibitor | 0.114 0.046 CID_9929090 | ||
| 0.081 | 0.01 | 0.081 | Potassium channel small-conductance Ca-activated blocker | 0.043 0.034 CID_23192118 0.042 0.035 CID_9929090 | ||
| 0.079 | 0.008 | 0.079 | Glycine transporter 1 inhibitor | 0.059 0.013 CID_9929090 | ||
| 0.115 | 0.045 | 0.16 | Pim-1 kinase inhibitor | 0.16 0.024 CID_23192118 0.132 0.035 CID_9929090 | CID_23192118 | |
| 0.143 | 0.073 | 0.18 | Sphingosine 1-phosphate receptor 5 antagonist | 0.18 0.024 CID_23192118 0.158 0.05 CID_9929090 | CID_23192118 | |
| 0.122 | 0.052 | 0.184 | Nav1.5 sodium channel blocker | 0.184 0.016 CID_23192118 | CID_23192118 | |
| 0.141 | 0.073 | 0.16 | Heat shock protein 70 antagonist | 0.16 0.028 CID_23192118 0.15 0.046 CID_9929090 | CID_23192118 | |
| 0.17 | 0.102 | 0.243 | Growth factor agonist | 0.243 0.035 CID_23192118 0.168 0.105 CID_9929090 | CID_23192118 | |
| 0.123 | 0.056 | 0.123 | Alpha 2b adrenoreceptor antagonist | |||
| 0.083 | 0.019 | 0.083 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.116 | 0.053 | 0.183 | Electron transport complex I inhibitor | 0.183 0.01 CID_23192118 | CID_23192118 | |
| 0.081 | 0.02 | 0.109 | 5 Hydroxytryptamine 5 antagonist | 0.109 0.013 CID_23192118 | CID_23192118 | |
| 0.206 | 0.149 | 0.235 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.235 0.087 CID_23192118 0.217 0.122 CID_9929090 | CID_23192118 | |
| 0.075 | 0.02 | 0.123 | Calcium channel P-type blocker | 0.123 0.004 CID_23192118 | CID_23192118 | |
| 0.076 | 0.021 | 0.076 | Potassium channel (Ca-activated) blocker | 0.069 0.028 CID_23192118 | ||
| 0.078 | 0.026 | 0.078 | Dopamine uptake inhibitor | 0.07 0.03 CID_9929090 | ||
| 0.099 | 0.047 | 0.099 | Acetylcholine agonist | |||
| 0.136 | 0.088 | 0.153 | Neuropeptide Y1 antagonist | 0.153 0.061 CID_23192118 0.123 0.115 CID_9929090 | CID_23192118 | |
| 0.067 | 0.02 | 0.079 | Lysine-specific demethylase 1A inhibitor | 0.079 0.013 CID_9929090 | CID_9929090 | |
| 0.07 | 0.025 | 0.169 | NMDA 2B receptor antagonist | 0.169 0.008 CID_23192118 0.101 0.015 CID_9929090 | CID_23192118 | |
| 0.081 | 0.039 | 0.081 | Calcium channel L-type blocker | |||
| 0.113 | 0.073 | 0.113 | Calcium channel N-type blocker | 0.103 0.09 CID_23192118 | ||
| 0.07 | 0.034 | 0.07 | Adrenaline uptake inhibitor | 0.058 0.046 CID_23192118 0.065 0.04 CID_9929090 | ||
| 0.073 | 0.041 | 0.126 | Acetylcholine M5 receptor agonist | 0.126 0.009 CID_23192118 | CID_23192118 | |
| 0.047 | 0.016 | 0.093 | 5 Hydroxytryptamine 2B agonist | 0.093 0.004 CID_23192118 | CID_23192118 | |
| 0.062 | 0.034 | 0.072 | Ca(v)3.2 blocker | 0.067 0.026 CID_23192118 0.072 0.02 CID_9929090 | CID_9929090 | |
| 0.041 | 0.012 | 0.063 | Cholesterol ester transfer protein antagonist | 0.063 0.004 CID_23192118 0.029 0.026 CID_9929090 | CID_23192118 | |
| 0.055 | 0.028 | 0.055 | Dopamine transporter inhibitor | 0.051 0.031 CID_9929090 | ||
| 0.096 | 0.071 | 0.212 | Nav1.1 sodium channel blocker | 0.212 0.017 CID_23192118 0.092 0.078 CID_9929090 | CID_23192118 | |
| 0.085 | 0.06 | 0.139 | Stem cell growth factor agonist | 0.139 0.023 CID_23192118 | CID_23192118 | |
| 0.145 | 0.119 | 0.186 | Catenin beta inhibitor | 0.186 0.045 CID_23192118 0.183 0.049 CID_9929090 | CID_23192118 | |
| 0.045 | 0.019 | 0.127 | TRPM8 blocker | 0.127 0.005 CID_23192118 0.037 0.028 CID_9929090 | CID_23192118 | |
| 0.055 | 0.031 | 0.081 | Glucose-6-phosphate translocase inhibitor | 0.081 0.011 CID_23192118 0.056 0.029 CID_9929090 | CID_23192118 | |
| 0.09 | 0.066 | 0.113 | Prolactin inhibitor | 0.113 0.044 CID_9929090 | CID_9929090 | |
| 0.055 | 0.032 | 0.095 | 5 Hydroxytryptamine 2 agonist | 0.095 0.01 CID_23192118 | CID_23192118 | |
| 0.092 | 0.07 | 0.115 | MAO A inhibitor | 0.099 0.065 CID_23192118 0.115 0.055 CID_9929090 | CID_9929090 | |
| 0.08 | 0.058 | 0.145 | Phosphodiesterase 11A inhibitor | 0.145 0.012 CID_23192118 | CID_23192118 | |
| 0.08 | 0.058 | 0.145 | Phosphodiesterase XI inhibitor | 0.145 0.012 CID_23192118 | CID_23192118 | |
| 0.06 | 0.039 | 0.066 | Beta tubulin antagonist | 0.066 0.036 CID_23192118 0.051 0.046 CID_9929090 | CID_23192118 | |
| 0.082 | 0.064 | 0.107 | Ca(v)2.2 blocker | 0.107 0.044 CID_23192118 | CID_23192118 | |
| 0.086 | 0.071 | 0.255 | Glutamate release inhibitor | 0.255 0.004 CID_23192118 | CID_23192118 | |
| 0.07 | 0.055 | 0.081 | Orexin receptor 1 antagonist | 0.081 0.034 CID_23192118 | CID_23192118 | |
| 0.052 | 0.038 | 0.076 | Alpha tubulin antagonist | 0.076 0.021 CID_23192118 0.051 0.04 CID_9929090 | CID_23192118 | |
| 0.063 | 0.051 | 0.063 | Neuronal nicotinic receptor antagonist | |||
| 0.066 | 0.059 | 0.085 | Epoxide hydrolase inhibitor | 0.085 0.037 CID_23192118 | CID_23192118 | |
| 0.042 | 0.035 | 0.078 | 5 Hydroxytryptamine 2C agonist | 0.078 0.012 CID_23192118 | CID_23192118 | |
| 0.052 | 0.045 | 0.052 | Potassium channel Kv1.5 blocker | |||
| 0.019 | 0.012 | 0.051 | Complement factor D inhibitor | 0.051 0.003 CID_23192118 | CID_23192118 | |
| 0.019 | 0.012 | 0.019 | Somatostatin 3 agonist | 0.019 0.012 CID_9929090 | ||
| 0.104 | 0.097 | 0.182 | Tubulin antagonist | 0.182 0.043 CID_23192118 | CID_23192118 | |
| 0.187 | 0.181 | 0.282 | 5 Hydroxytryptamine uptake stimulant | 0.282 0.055 CID_23192118 0.232 0.1 CID_9929090 | CID_23192118 | |
| 0.098 | 0.093 | 0.189 | MAO inhibitor | 0.189 0.044 CID_23192118 0.128 0.07 CID_9929090 | CID_23192118 | |
| 0.04 | 0.036 | 0.041 | DNA gyrase subunit A inhibitor | 0.041 0.032 CID_9929090 | CID_9929090 | |
| 0.049 | 0.045 | 0.049 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.055 | 0.051 | 0.055 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.055 | 0.052 | 0.128 | 5 Hydroxytryptamine 2A agonist | 0.128 0.008 CID_23192118 | CID_23192118 | |
| 0.022 | 0.019 | 0.028 | Epoxide hydrolase 2 inhibitor | 0.028 0.015 CID_23192118 | CID_23192118 | |
| 0.065 | 0.062 | 0.085 | Histone deacetylase SIRT1 stimulant | 0.075 0.049 CID_23192118 0.085 0.039 CID_9929090 | CID_9929090 | |
| 0.065 | 0.062 | 0.085 | Histone deacetylase stimulant | 0.075 0.049 CID_23192118 0.085 0.039 CID_9929090 | CID_9929090 | |
| 0.094 | 0.091 | 0.278 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.278 0.014 CID_23192118 | CID_23192118 | |
| 0.07 | 0.068 | 0.07 | Acetylcholine nicotinic antagonist | |||
| 0.102 | 0.102 | 0.103 | Acetylcholinesterase inhibitor | 0.103 0.101 CID_23192118 | CID_23192118 | |
| 0.092 | 0.092 | 0.274 | Abl kinase inhibitor | 0.274 0.014 CID_23192118 | CID_23192118 | |
| 0.058 | 0.06 | 0.062 | Prolactin release inhibitor | 0.062 0.043 CID_9929090 | CID_9929090 | |
| 0.027 | 0.03 | 0.029 | Epoxide hydrolase 1 inhibitor | 0.029 0.025 CID_23192118 | CID_23192118 | |
| 0.058 | 0.062 | 0.077 | Orexin receptor antagonist | 0.077 0.03 CID_23192118 | CID_23192118 | |
| 0.034 | 0.038 | 0.079 | Dopamine D5 agonist | 0.079 0.006 CID_9929090 | CID_9929090 | |
| 0.054 | 0.059 | 0.061 | 5 Hydroxytryptamine 5A antagonist | 0.061 0.043 CID_23192118 | CID_23192118 | |
| 0.049 | 0.054 | 0.056 | CXC chemokine 4 receptor antagonist | 0.056 0.045 CID_9929090 | CID_9929090 | |
| 0.037 | 0.042 | 0.059 | Glycine transporter 2 inhibitor | 0.059 0.026 CID_23192118 0.055 0.028 CID_9929090 | CID_23192118 | |
| 0.019 | 0.025 | 0.029 | Dopamine D1 agonist | 0.029 0.01 CID_23192118 0.026 0.012 CID_9929090 | CID_23192118 | |
| 0.138 | 0.145 | 0.251 | Anticonvulsant | 0.251 0.057 CID_23192118 | CID_23192118 | |
| 0.093 | 0.102 | 0.106 | Acetylcholine antagonist | 0.106 0.084 CID_9929090 | CID_9929090 | |
| 0.074 | 0.083 | 0.099 | Ca(v)3.1 blocker | 0.099 0.024 CID_23192118 | CID_23192118 | |
| 0.076 | 0.086 | 0.087 | Pim-3 kinase inhibitor | 0.087 0.063 CID_23192118 0.08 0.077 CID_9929090 | CID_23192118 | |
| 0.175 | 0.187 | 0.278 | Tyrosine 3 hydroxylase inhibitor | 0.278 0.046 CID_23192118 0.2 0.136 CID_9929090 | CID_23192118 | |
| 0.012 | 0.024 | 0.021 | Prokineticin receptor 1 antagonist | 0.021 0.005 CID_23192118 | CID_23192118 | |
| 0.078 | 0.09 | 0.118 | Polo-like kinase-1 inhibitor | 0.118 0.031 CID_23192118 | CID_23192118 | |
| 0.071 | 0.084 | 0.222 | Myeloperoxidase inhibitor | 0.222 0.005 CID_23192118 0.091 0.048 CID_9929090 | CID_23192118 | |
| 0.035 | 0.048 | 0.067 | Sphingosine 1-phosphate receptor agonist | 0.067 0.012 CID_23192118 | CID_23192118 | |
| 0.092 | 0.107 | 0.106 | Cholinergic antagonist | 0.106 0.088 CID_9929090 | CID_9929090 | |
| 0.034 | 0.049 | 0.038 | Plasmepsin II inhibitor | 0.038 0.037 CID_23192118 | CID_23192118 | |
| 0.067 | 0.084 | 0.172 | NMDA receptor antagonist | 0.101 0.047 CID_23192118 0.172 0.019 CID_9929090 | CID_9929090 | |
| 0.222 | 0.239 | 0.279 | Calcium channel L-type activator | 0.279 0.175 CID_9929090 | CID_9929090 | |
| 0.052 | 0.069 | 0.064 | Corticotropin releasing factor 2 receptor antagonist | 0.064 0.038 CID_23192118 | CID_23192118 | |
| 0.074 | 0.091 | 0.161 | Aminoacyl-tRNA synthetase inhibitor | 0.161 0.016 CID_23192118 0.082 0.074 CID_9929090 | CID_23192118 | |
| 0.05 | 0.069 | 0.123 | Potassium channel intermediate-conductance Ca-activated blocker | 0.123 0.005 CID_23192118 | CID_23192118 | |
| 0.046 | 0.066 | 0.053 | 5 Hydroxytryptamine 7 agonist | 0.053 0.047 CID_23192118 | CID_23192118 | |
| 0.114 | 0.135 | 0.187 | Polo-like kinase-3 inhibitor | 0.187 0.052 CID_23192118 | CID_23192118 | |
| 0.073 | 0.095 | 0.104 | Breast cancer-resistant protein inhibitor | 0.104 0.051 CID_23192118 | CID_23192118 | |
| 0.036 | 0.06 | 0.111 | Plasminogen activator inhibitor antagonist | 0.111 0.008 CID_23192118 0.049 0.034 CID_9929090 | CID_23192118 | |
| 0.051 | 0.075 | 0.117 | Nav1.7 sodium channel blocker | 0.117 0.018 CID_23192118 | CID_23192118 | |
| 0.009 | 0.034 | 0.015 | Purinergic P2Y1 antagonist | 0.015 0.013 CID_23192118 | CID_23192118 | |
| 0.023 | 0.051 | 0.039 | Dipeptidyl peptidase II inhibitor | 0.039 0.015 CID_23192118 | CID_23192118 | |
| 0.078 | 0.11 | 0.16 | Adenylate cyclase inhibitor | 0.16 0.039 CID_9929090 | CID_9929090 | |
| 0.021 | 0.057 | 0.032 | Hedgehog signaling activator | 0.032 0.01 CID_23192118 | CID_23192118 | |
| 0.012 | 0.049 | 0.024 | Imidazoline I1 receptor antagonist | 0.024 0.01 CID_23192118 | CID_23192118 | |
| 0.06 | 0.099 | 0.08 | Opioid kappa receptor antagonist | 0.08 0.058 CID_9929090 | CID_9929090 | |
| 0.057 | 0.101 | 0.166 | MAO B inhibitor | 0.166 0.032 CID_23192118 0.081 0.075 CID_9929090 | CID_23192118 | |
| 0.029 | 0.076 | 0.056 | Vanilloid 3 antagonist | 0.056 0.005 CID_23192118 | CID_23192118 | |
| 0.036 | 0.084 | 0.053 | Alpha-mannosidase inhibitor | 0.053 0.038 CID_9929090 | CID_9929090 | |
| 0.005 | 0.053 | 0.012 | Imidazoline I2 receptor antagonist | 0.012 0.007 CID_23192118 | CID_23192118 | |
| 0.016 | 0.065 | 0.035 | Orexin receptor 2 antagonist | 0.035 0.026 CID_23192118 | CID_23192118 | |
| 0.045 | 0.095 | 0.067 | Polo-like kinase-2 inhibitor | 0.067 0.056 CID_23192118 | CID_23192118 | |
| 0.016 | 0.066 | 0.028 | Calcium-sensing receptor agonist | 0.028 0.016 CID_23192118 | CID_23192118 | |
| 0.043 | 0.096 | 0.067 | Adenine nucleotide translocase inhibitor | 0.067 0.018 CID_23192118 0.054 0.044 CID_9929090 | CID_23192118 | |
| 0.024 | 0.08 | 0.052 | Sphingosine 1-phosphate receptor 1 agonist | 0.052 0.018 CID_23192118 | CID_23192118 | |
| 0.036 | 0.092 | 0.061 | TRPA1 antagonist | 0.061 0.042 CID_23192118 | CID_23192118 | |
| 0.072 | 0.131 | 0.177 | AMP-activated protein kinase stimulant | 0.177 0.015 CID_23192118 0.098 0.073 CID_9929090 | CID_23192118 | |
| 0.04 | 0.101 | 0.06 | Sphingosine 1-phosphate receptor 1 antagonist | 0.06 0.03 CID_23192118 | CID_23192118 | |
| 0.083 | 0.146 | 0.365 | NADPH oxidase inhibitor | 0.365 0.006 CID_23192118 | CID_23192118 | |
| 0.088 | 0.152 | 0.14 | Protein kinase stimulant | 0.14 0.075 CID_23192118 | CID_23192118 | |
| 0.047 | 0.111 | 0.069 | Beta 3 adrenoreceptor antagonist | 0.069 0.036 CID_23192118 | CID_23192118 | |
| 0.11 | 0.177 | 0.133 | Antipruritic | 0.133 0.117 CID_23192118 | CID_23192118 | |
| 0.036 | 0.105 | 0.063 | Vanilloid 2 antagonist | 0.063 0.019 CID_23192118 | CID_23192118 | |
| 0.029 | 0.101 | 0.064 | Phosphodiesterase II inhibitor | 0.064 0.028 CID_23192118 | CID_23192118 | |
| 0.025 | 0.098 | 0.037 | Phenylethanolamine N methyltransferase inhibitor | 0.037 0.035 CID_23192118 | CID_23192118 | |
| 0.023 | 0.098 | 0.038 | Tryptophan 5 hydroxylase inhibitor | 0.038 0.02 CID_23192118 | CID_23192118 | |
| 0.047 | 0.125 | 0.106 | 5 Hydroxytryptamine 2C antagonist | 0.106 0.042 CID_23192118 | CID_23192118 | |
| 0.059 | 0.138 | 0.091 | Expectorant | 0.091 0.08 CID_23192118 | CID_23192118 | |
| 0.026 | 0.109 | 0.063 | Beta 2 adrenoreceptor antagonist | 0.063 0.022 CID_23192118 | CID_23192118 | |
| 0.035 | 0.119 | 0.073 | Phosphodiesterase 4B inhibitor | 0.073 0.041 CID_23192118 | CID_23192118 | |
| 0.024 | 0.109 | 0.056 | Phosphodiesterase 2A inhibitor | 0.056 0.027 CID_23192118 | CID_23192118 | |
| 0.045 | 0.131 | 0.102 | Bcr-Abl kinase inhibitor | 0.102 0.039 CID_23192118 | CID_23192118 | |
| 0.043 | 0.13 | 0.075 | Ryanodine receptor antagonist | 0.075 0.012 CID_23192118 | CID_23192118 | |
| 0.046 | 0.137 | 0.076 | Potassium channel (Tandem pore domain) blocker | 0.076 0.046 CID_23192118 | CID_23192118 | |
| 0.053 | 0.144 | 0.078 | Histamine H2 receptor antagonist | 0.078 0.07 CID_23192118 | CID_23192118 | |
| 0.017 | 0.109 | 0.035 | Peroxisome proliferator-activated receptor delta antagonist | 0.035 0.021 CID_23192118 | CID_23192118 | |
| 0.044 | 0.135 | 0.066 | Secretase beta inhibitor | 0.066 0.056 CID_23192118 | CID_23192118 | |
| 0.031 | 0.131 | 0.054 | Sphingosine kinase 2 inhibitor | 0.054 0.04 CID_23192118 | CID_23192118 | |
| 0.021 | 0.122 | 0.045 | Protein kinase (CK1) epsilon inhibitor | 0.045 0.018 CID_23192118 | CID_23192118 | |
| 0.021 | 0.122 | 0.033 | Antibiotic Aminoglycoside-like | 0.033 0.031 CID_23192118 | CID_23192118 | |
| 0.059 | 0.162 | 0.092 | Thioredoxin reductase inhibitor | 0.092 0.038 CID_23192118 | CID_23192118 | |
| 0.026 | 0.13 | 0.041 | Glucagon-like peptide 1 receptor antagonist | 0.041 0.024 CID_23192118 | CID_23192118 | |
| 0.038 | 0.145 | 0.124 | Rho-associated kinase II inhibitor | 0.124 0.024 CID_23192118 | CID_23192118 | |
| 0.024 | 0.134 | 0.062 | 5 Hydroxytryptamine agonist | 0.062 0.053 CID_23192118 | CID_23192118 | |
| 0.094 | 0.206 | 0.169 | Melanin inhibitor | 0.169 0.06 CID_23192118 | CID_23192118 | |
| 0.01 | 0.121 | 0.048 | Peroxisome proliferator-activated receptor delta agonist | 0.048 0.013 CID_23192118 | CID_23192118 | |
| 0.024 | 0.136 | 0.064 | Beta 1 adrenoreceptor antagonist | 0.064 0.032 CID_23192118 | CID_23192118 | |
| 0.062 | 0.176 | 0.083 | Transforming growth factor beta 3 antagonist | 0.083 0.054 CID_23192118 | CID_23192118 | |
| 0.03 | 0.145 | 0.046 | Bombesin 2 receptor antagonist | 0.046 0.04 CID_23192118 | CID_23192118 | |
| 0.023 | 0.142 | 0.083 | Protease activated receptor antagonist | 0.083 0.021 CID_23192118 | CID_23192118 | |
| 0.079 | 0.2 | 0.133 | Sphingosine 1-phosphate receptor 4 antagonist | 0.133 0.052 CID_23192118 | CID_23192118 | |
| 0.055 | 0.177 | 0.146 | Nitric-oxide synthase inhibitor | 0.146 0.024 CID_23192118 | CID_23192118 | |
| 0.01 | 0.133 | 0.029 | Potassium channel small-conductance Ca-activated activator | 0.029 0.024 CID_23192118 | CID_23192118 | |
| 0.05 | 0.18 | 0.162 | GABA C receptor agonist | 0.162 0.03 CID_23192118 0.094 0.074 CID_9929090 | CID_23192118 | |
| 0.096 | 0.226 | 0.146 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.146 0.08 CID_23192118 | CID_23192118 | |
| 0.05 | 0.18 | 0.234 | GABA B receptor agonist | 0.234 0.003 CID_23192118 | CID_23192118 | |
| 0.035 | 0.166 | 0.097 | Aryl hydrocarbon receptor antagonist | 0.097 0.015 CID_23192118 | CID_23192118 | |
| 0.031 | 0.164 | 0.075 | Beta adrenoreceptor antagonist | 0.075 0.031 CID_23192118 | CID_23192118 | |
| 0.119 | 0.254 | 0.231 | 5 Hydroxytryptamine release stimulant | 0.231 0.099 CID_23192118 | CID_23192118 | |
| 0.055 | 0.194 | 0.107 | Proteasome inhibitor | 0.107 0.079 CID_23192118 | CID_23192118 | |
| 0.012 | 0.152 | 0.059 | Peroxisome proliferator-activated receptor alpha agonist | 0.059 0.026 CID_23192118 | CID_23192118 | |
| 0.095 | 0.238 | 0.199 | Free radical scavenger | 0.199 0.099 CID_23192118 0.169 0.125 CID_9929090 | CID_23192118 | |
| 0.132 | 0.277 | 0.267 | Nitric-oxide synthase stimulant | 0.267 0.022 CID_23192118 | CID_23192118 | |
| 0.041 | 0.186 | 0.062 | Beta 2 adrenoreceptor agonist | 0.062 0.042 CID_23192118 0.059 0.056 CID_9929090 | CID_23192118 | |
| 0.054 | 0.205 | 0.106 | Mucolytic | 0.106 0.07 CID_23192118 | CID_23192118 | |
| 0.012 | 0.164 | 0.047 | Glutamate (mGluR group II) antagonist | 0.047 0.018 CID_23192118 | CID_23192118 | |
| 0.027 | 0.182 | 0.084 | Na+ K+ transporting ATPase inhibitor | 0.084 0.047 CID_23192118 | CID_23192118 | |
| 0.111 | 0.267 | 0.265 | Superoxide dismutase inhibitor | 0.265 0.065 CID_23192118 | CID_23192118 | |
| 0.009 | 0.165 | 0.121 | Diamine oxidase inhibitor | 0.121 0.004 CID_23192118 | CID_23192118 | |
| 0.073 | 0.229 | 0.135 | Protein kinase (CK1) gamma 3 inhibitor | 0.135 0.108 CID_23192118 | CID_23192118 | |
| 0.125 | 0.288 | 0.201 | Vasodilator, peripheral | 0.201 0.175 CID_23192118 | CID_23192118 | |
| 0.003 | 0.167 | 0.015 | G-protein-coupled receptor 120 agonist | 0.015 0.014 CID_23192118 | CID_23192118 | |
| 0.017 | 0.183 | 0.064 | Dihydrofolate reductase inhibitor | 0.064 0.009 CID_23192118 | CID_23192118 | |
| 0.003 | 0.172 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.007 CID_23192118 | CID_23192118 | |
| 0.016 | 0.185 | 0.036 | Melatonin receptor 1A agonist | 0.036 0.018 CID_23192118 | CID_23192118 | |
| 0.116 | 0.285 | 0.275 | Transcription factor STAT3 inhibitor | 0.275 0.066 CID_23192118 | CID_23192118 | |
| 0.078 | 0.251 | 0.153 | DNA repair enzyme inhibitor | 0.153 0.029 CID_23192118 | CID_23192118 | |
| 0.032 | 0.205 | 0.081 | Metalloproteinase-9 inhibitor | 0.081 0.043 CID_23192118 | CID_23192118 | |
| 0.019 | 0.194 | 0.128 | Glutamate (mGluR group III) agonist | 0.128 0.006 CID_23192118 | CID_23192118 | |
| 0.015 | 0.193 | 0.037 | Glutamate (mGluR3) agonist | 0.037 0.013 CID_23192118 | CID_23192118 | |
| 0.078 | 0.258 | 0.195 | Hemostatic | 0.195 0.034 CID_23192118 | CID_23192118 | |
| 0.007 | 0.188 | 0.04 | Phosphoglycerate kinase inhibitor | 0.04 0.019 CID_23192118 | CID_23192118 | |
| 0.007 | 0.188 | 0.018 | Factor IX inhibitor | 0.018 0.014 CID_23192118 | CID_23192118 | |
| 0.011 | 0.195 | 0.035 | Alpha 1d adrenoreceptor agonist | 0.035 0.033 CID_23192118 | CID_23192118 | |
| 0.11 | 0.298 | 0.195 | Hypoxia-inducible factor 1 alpha inhibitor | 0.195 0.158 CID_23192118 | CID_23192118 | |
| 0.038 | 0.226 | 0.075 | Sphingosine 1-phosphate receptor antagonist | 0.075 0.058 CID_23192118 | CID_23192118 | |
| 0.048 | 0.244 | 0.143 | Thrombolytic | 0.143 0.087 CID_23192118 | CID_23192118 | |
| 0.019 | 0.216 | 0.053 | Collagenase 3 inhibitor | 0.053 0.052 CID_23192118 | CID_23192118 | |
| 0.018 | 0.216 | 0.045 | Cholesterol esterase inhibitor | 0.045 0.038 CID_23192118 | CID_23192118 | |
| 0.024 | 0.223 | 0.111 | Factor IXa inhibitor | 0.111 0.008 CID_23192118 | CID_23192118 | |
| 0.047 | 0.247 | 0.123 | Beta amyloid protein antagonist | 0.123 0.065 CID_23192118 | CID_23192118 | |
| 0.016 | 0.217 | 0.071 | Peroxisome proliferator-activated receptor gamma agonist | 0.071 0.048 CID_23192118 | CID_23192118 | |
| 0.153 | 0.354 | 0.498 | Cyclophilin D inhibitor | 0.498 0.051 CID_23192118 | CID_23192118 | |
| 0.105 | 0.307 | 0.287 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.287 0.028 CID_23192118 | CID_23192118 | |
| 0.013 | 0.214 | 0.06 | Neutrophil collagenase inhibitor | 0.06 0.05 CID_23192118 | CID_23192118 | |
| 0.131 | 0.334 | 0.252 | Antibacterial | 0.252 0.175 CID_23192118 0.25 0.177 CID_9929090 | CID_23192118 | |
| 0.023 | 0.226 | 0.076 | Phosphodiesterase IV inhibitor | 0.076 0.066 CID_23192118 | CID_23192118 | |
| 0.029 | 0.234 | 0.121 | Potassium channel (Ca-activated) activator | 0.121 0.04 CID_23192118 | CID_23192118 | |
| 0.039 | 0.253 | 0.095 | Chelator | 0.095 0.085 CID_9929090 | CID_9929090 | |
| 0.049 | 0.265 | 0.113 | D-Ala-D-Ala ligase inhibitor | 0.113 0.017 CID_23192118 | CID_23192118 | |
| 0.068 | 0.292 | 0.166 | Platelet adhesion inhibitor | 0.166 0.091 CID_23192118 | CID_23192118 | |
| 0.005 | 0.234 | 0.031 | Glutamate (mGluR2) antagonist | 0.031 0.019 CID_23192118 | CID_23192118 | |
| 0.009 | 0.239 | 0.049 | Factor VIIa inhibitor | 0.049 0.02 CID_23192118 | CID_23192118 | |
| 0.035 | 0.272 | 0.114 | HIV-1 integrase (Overall Integration) inhibitor | 0.114 0.043 CID_23192118 | CID_23192118 | |
| 0.048 | 0.286 | 0.153 | Cytokine production inhibitor | 0.153 0.06 CID_23192118 | CID_23192118 | |
| 0.004 | 0.244 | 0.016 | Dipeptidyl peptidase VIII inhibitor | 0.016 0.009 CID_23192118 | CID_23192118 | |
| 0.032 | 0.274 | 0.072 | Peroxisome proliferator-activated receptor gamma antagonist | 0.072 0.049 CID_23192118 | CID_23192118 | |
| 0.004 | 0.246 | 0.026 | Dipeptidyl peptidase IX inhibitor | 0.026 0.006 CID_23192118 | CID_23192118 | |
| 0.025 | 0.274 | 0.107 | Inducible nitric-oxide synthase inhibitor | 0.107 0.031 CID_23192118 | CID_23192118 | |
| 0.012 | 0.264 | 0.045 | Nerve growth factor antagonist | 0.045 0.026 CID_23192118 | CID_23192118 | |
| 0.023 | 0.277 | 0.052 | Dihydroorotate oxidase inhibitor | 0.052 0.046 CID_23192118 | CID_23192118 | |
| 0.07 | 0.327 | 0.148 | Tumour necrosis factor antagonist | 0.148 0.104 CID_23192118 | CID_23192118 | |
| 0.119 | 0.378 | 0.333 | Calcium channel activator | 0.333 0.062 CID_23192118 | CID_23192118 | |
| 0.014 | 0.274 | 0.075 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.075 0.027 CID_23192118 | CID_23192118 | |
| 0.042 | 0.304 | 0.092 | Granulocyte macrophage colony stimulating factor agonist | 0.092 0.047 CID_23192118 | CID_23192118 | |
| 0.041 | 0.312 | 0.16 | Interleukin 1b antagonist | 0.16 0.033 CID_23192118 | CID_23192118 | |
| 0.046 | 0.318 | 0.147 | Anticoagulant | 0.147 0.083 CID_23192118 | CID_23192118 | |
| 0.045 | 0.322 | 0.105 | Estrogen antagonist | 0.105 0.087 CID_9929090 | CID_9929090 | |
| 0.048 | 0.326 | 0.133 | Cell wall synthesis inhibitor | 0.133 0.083 CID_23192118 | CID_23192118 | |
| 0.014 | 0.292 | 0.076 | Amidase inhibitor | 0.076 0.041 CID_23192118 | CID_23192118 | |
| 0.12 | 0.402 | 0.174 | 5 Hydroxytryptamine 3E antagonist | 0.174 0.124 CID_23192118 | CID_23192118 | |
| 0.141 | 0.426 | 0.3 | 5 Hydroxytryptamine release inhibitor | 0.3 0.165 CID_23192118 | CID_23192118 | |
| 0.03 | 0.316 | 0.091 | Sphingomyelinase inhibitor | 0.091 0.071 CID_23192118 | CID_23192118 | |
| 0.023 | 0.31 | 0.056 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.056 0.052 CID_23192118 | CID_23192118 | |
| 0.053 | 0.346 | 0.166 | Thiol protease inhibitor | 0.166 0.057 CID_23192118 | CID_23192118 | |
| 0.062 | 0.364 | 0.167 | 3C-like protease (Human coronavirus) inhibitor | 0.167 0.078 CID_23192118 | CID_23192118 | |
| 0.032 | 0.335 | 0.13 | Alkaline phosphatase inhibitor | 0.13 0.076 CID_23192118 | CID_23192118 | |
| 0.005 | 0.31 | 0.03 | Liver X receptor beta agonist | 0.03 0.028 CID_23192118 | CID_23192118 | |
| 0.029 | 0.335 | 0.124 | GABA C receptor antagonist | 0.124 0.048 CID_23192118 | CID_23192118 | |
| 0.023 | 0.334 | 0.047 | Factor III inhibitor | 0.047 0.044 CID_23192118 | CID_23192118 | |
| 0.014 | 0.325 | 0.136 | Monophenol monooxygenase inhibitor | 0.136 0.053 CID_23192118 | CID_23192118 | |
| 0.072 | 0.394 | 0.163 | Papain-like protease (SARS coronavirus) inhibitor | 0.163 0.024 CID_23192118 | CID_23192118 | |
| 0.074 | 0.398 | 0.233 | Transcription factor STAT inhibitor | 0.233 0.1 CID_23192118 | CID_23192118 | |
| 0.017 | 0.344 | 0.06 | Epithelial sodium channel blocker | 0.06 0.029 CID_23192118 | CID_23192118 | |
| 0.08 | 0.408 | 0.144 | Neurotensin receptor agonist | 0.144 0.118 CID_23192118 | CID_23192118 | |
| 0.053 | 0.383 | 0.127 | Sphingosine 1-phosphate receptor 2 antagonist | 0.127 0.081 CID_23192118 | CID_23192118 | |
| 0.068 | 0.4 | 0.271 | Transcription factor NF kappa B inhibitor | 0.271 0.112 CID_23192118 | CID_23192118 | |
| 0.013 | 0.349 | 0.086 | Sphingosine 1-phosphate receptor 4 agonist | 0.086 0.033 CID_23192118 | CID_23192118 | |
| 0.014 | 0.351 | 0.049 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.049 0.045 CID_23192118 | CID_23192118 | |
| 0.061 | 0.399 | 0.13 | Vanilloid 1 agonist | 0.13 0.067 CID_23192118 | CID_23192118 | |
| 0.005 | 0.347 | 0.114 | Plasma kallikrein inhibitor | 0.114 0.005 CID_23192118 | CID_23192118 | |
| 0.07 | 0.421 | 0.194 | Histone acetyltransferase inhibitor | 0.194 0.079 CID_23192118 | CID_23192118 | |
| 0.037 | 0.389 | 0.13 | DOPA decarboxylase inhibitor | 0.13 0.035 CID_23192118 | CID_23192118 | |
| 0.06 | 0.415 | 0.136 | ATPase inhibitor | 0.136 0.129 CID_23192118 | CID_23192118 | |
| 0.031 | 0.388 | 0.062 | Transcription factor RelA inhibitor | 0.062 0.047 CID_23192118 | CID_23192118 | |
| 0.015 | 0.375 | 0.098 | CYP2A6 inhibitor | 0.098 0.037 CID_23192118 | CID_23192118 | |
| 0.041 | 0.416 | 0.078 | Estrogen-related receptor beta agonist | 0.078 0.074 CID_23192118 | CID_23192118 | |
| 0.01 | 0.397 | 0.121 | Kallikrein inhibitor | 0.121 0.008 CID_23192118 | CID_23192118 | |
| 0.033 | 0.425 | 0.093 | Lanosterol 14 alpha demethylase inhibitor | 0.093 0.067 CID_23192118 | CID_23192118 | |
| 0.112 | 0.508 | 0.288 | Caspase 9 stimulant | 0.288 0.207 CID_23192118 | CID_23192118 | |
| 0.036 | 0.433 | 0.11 | Interleukin 1 antagonist | 0.11 0.105 CID_23192118 | CID_23192118 | |
| 0.026 | 0.427 | 0.121 | Kallikrein 1 inhibitor | 0.121 0.009 CID_23192118 | CID_23192118 | |
| 0.016 | 0.421 | 0.075 | Glutamate (mGluR7) antagonist | 0.075 0.034 CID_23192118 | CID_23192118 | |
| 0.033 | 0.442 | 0.195 | Insulin sensitizer | 0.195 0.078 CID_23192118 | CID_23192118 | |
| 0.033 | 0.452 | 0.192 | Carbonic anhydrase XV inhibitor | 0.192 0.02 CID_23192118 | CID_23192118 | |
| 0.007 | 0.431 | 0.06 | Tryptase inhibitor | 0.06 0.009 CID_23192118 | CID_23192118 | |
| 0.018 | 0.445 | 0.057 | Purinergic P2X1 antagonist | 0.057 0.048 CID_23192118 | CID_23192118 | |
| 0.013 | 0.442 | 0.049 | Dopamine beta hydroxylase inhibitor | 0.049 0.033 CID_23192118 | CID_23192118 | |
| 0.013 | 0.443 | 0.043 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.043 0.025 CID_23192118 | CID_23192118 | |
| 0.019 | 0.451 | 0.101 | Cystathionine beta-synthase inhibitor | 0.101 0.076 CID_23192118 | CID_23192118 | |
| 0.02 | 0.471 | 0.176 | Aryl hydrocarbon receptor agonist | 0.176 0.117 CID_23192118 | CID_23192118 | |
| 0.015 | 0.468 | 0.09 | Carbonic anhydrase XIII inhibitor | 0.09 0.043 CID_23192118 | CID_23192118 | |
| 0.024 | 0.479 | 0.141 | Phospholipase A2 inhibitor | 0.141 0.085 CID_23192118 | CID_23192118 | |
| 0.033 | 0.493 | 0.183 | Aldehyde oxidase inhibitor | 0.183 0.114 CID_23192118 | CID_23192118 | |
| 0.021 | 0.482 | 0.089 | Carbonic anhydrase VI inhibitor | 0.089 0.048 CID_23192118 | CID_23192118 | |
| 0.031 | 0.508 | 0.181 | Peroxidase inhibitor | 0.181 0.065 CID_23192118 | CID_23192118 | |
| 0.047 | 0.533 | 0.2 | Antithrombotic | 0.2 0.177 CID_23192118 | CID_23192118 | |
| 0.027 | 0.559 | 0.164 | Succinate dehydrogenase inhibitor | 0.164 0.089 CID_23192118 | CID_23192118 | |
| 0.058 | 0.601 | 0.211 | GABA C receptor rho-3 antagonist | 0.211 0.194 CID_23192118 | CID_23192118 | |
| 0.017 | 0.599 | 0.065 | Exportin-1 inhibitor | 0.065 0.057 CID_23192118 | CID_23192118 | |
| 0.007 | 0.625 | 0.101 | Maillard reaction inhibitor | 0.101 0.016 CID_23192118 | CID_23192118 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |